Jump to content

News sharing for NSCLC


Recommended Posts

Aventis says Taxotere helps fight early lung cancer

Thu August 14, 2003 03:25 AM ET

In PARIS story headlined "Aventis says Taxotere helps fight early lung cancer" please read in first paragraph ...Franco-German... instead of ...Franco-American... (correcting nationality)

A corrected version follows:

PARIS, Aug 14 (Reuters) - Franco-German drug maker Aventis AVEP.PA said on Thursday recent studies showed its Taxotere drug was beneficial in initial chemotherapy to fight non-small cell lung cancer.

A French Phase II study showed a doubling of the three year survival rate when Taxotere was administered with chemotherapy agent cisplatin followed by cancer-fighting drug vinorelbine versus a dose of cisplatin and vinorelbine followed by Taxotere, Aventis said.

A German Phase II study showed a median survival rate of 8.5 months compared with 6.2 months when Taxotere was administered before gemcitabine as opposed to afterwards in advanced non-small cell lung cancer, Aventis said.

A third study showed elderly patients with advanced non-small lung cancer who received Taxotere with a platinum compound had an improved median survival compared to a combined dose of vinorelbine and cisplatin, Aventis said.

The studies were presented at the 10th World Lung Conference in Vancouver, Canada

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.